Leading Healthcare Investors, including Janus Henderson Investors, Invus, Longaeva Partners, ARK Invest, Driehaus Capital ...
(THE CONVERSATION) The 2026 Nobel Prize in physiology or medicine honored Karl Deisseroth, Peter Hegemann and Georg Nagel for their work developing optogenetics – a technique that allows researchers ...
For decades, maps have helped people get from Point A to Point B. Today, they are increasingly becoming places to discover what comes next.
Recursion Pharmaceuticals, Inc. (“Recursion”) (NASDAQ: RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and development decoding biology to radically ...
The drugmaker will pay AI therapeutics company Insitro $40 million upfront and up to $1.46 billion subject to meeting targets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results